Mine sisu juurde

hydrochlorothiazide

Lehekülje sisu ei toetata teistes keeltes.

chemical compound

Välised allikad

CAS Registry Number
MeSH descriptor ID
D006852

teema nimetus kujul: Hydrochlorothiazide

MeSH concept ID
NSC number
ChEMBL ID
Gran Enciclopèdia Catalana ID
Human Metabolome Database ID
MeSH tree code
AICS Chemical ID (BEING DELETED)
ECHA Substance Infocard ID
PDB structure ID
DrugCentral ID
Probes And Drugs ID
NDF-RT ID
Freebase
Reaxys registry number
625101[11]
PubChem CID
UniChem compound ID
Quora topic ID
PDB ligand ID
SPLASH
KEGG ID
OpenAlex ID
KBpedia ID
InChIKey
DrugBank ID
ChEBI ID
5778[3][17]

mapping relation type: täpne vaste

WikiProjectMed ID
UNII
HSDB ID
SureChEMBL ID
ATC code
Microsoft Academic ID
Guide to Pharmacology Ligand ID
DSSTOX compound identifier
WordNet 3.1 Synset ID
03557349-n[21]
Gran Enciclopèdia Catalana ID (former scheme)
UMLS CUI
DSSTox substance ID
CAB ID
ChemSpider ID
EC number
200-403-3[1]
InChI
MedlinePlus drug identifier
World Health Organisation international non-proprietary name numeric ID
MassBank accession ID
CAMEO Chemicals ID
RxNorm ID

üksikjuht nähtusest

type of chemical entity

mille alamklass

thiazide[26]

kasutus

keemiline struktuur

image of molecular model or crystal lattice model

kujutab: space-filling model

mass/kaal

296,964 aatommassiühik[27]

chemical formula

C₇H₈ClN₃O₄S₂[12]

canonical SMILES

C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl[12]

sulamistemperatuur

269 Celsiuse skaala[28]

defined daily dose

25 milligram[29]

route of administration: oral administration

active ingredient in

Microzide[30]

World Health Organisation international non-proprietary name

hydrochlorothiazide[11][31]

medical condition treated

anasarka[32]
congestive heart failure[32]

significant drug interaction

desmopressin[34]

side effect: Veemürgitus

carbamazepin[35]

side effect: Veemürgitus

dronedarone[34]

side effect: Achor-Smith syndrom

triamcinolone[34]

side effect: Achor-Smith syndrom

methylprednisolone[34]

side effect: Achor-Smith syndrom

prednisone[34]

side effect: Achor-Smith syndrom

fludrocortisone[34]

side effect: Achor-Smith syndrom

cortisol[34]

side effect: Achor-Smith syndrom

prednisolone[34]

side effect: Achor-Smith syndrom

droperidol[34]

side effect: Achor-Smith syndrom

Diarseentrioksiid[34]

side effect: Achor-Smith syndrom

sotalol[35]

side effect: Achor-Smith syndrom

liitium[34]

side effect: Achor-Smith syndrom

nabumetone[35]

side effect: Veemürgitus

celecoxib[35]

side effect: Veemürgitus

Diclofenac[35]

side effect: Veemürgitus

piroxicam[35]

side effect: Veemürgitus

meloksikaam[35]

side effect: Veemürgitus

(RS)-fenoprofen[35]

side effect: Veemürgitus

(+-)-flurbiprofen[35]

side effect: Veemürgitus

(RS)-ketoprofen[35]

side effect: Veemürgitus

(RS)-etodolac[35]

side effect: Veemürgitus

sulindac[35]

side effect: Veemürgitus

parecoxib[35]

side effect: Veemürgitus

aceclofenac[35]

side effect: Veemürgitus

tenoxicam[35]

side effect: Veemürgitus

nabumetone[35]

side effect: Äge neerukahjustus

celecoxib[35]

side effect: Äge neerukahjustus

Diclofenac[35]

side effect: Äge neerukahjustus

piroxicam[35]

side effect: Äge neerukahjustus

meloksikaam[35]

side effect: Äge neerukahjustus

(RS)-fenoprofen[35]

side effect: Äge neerukahjustus

(+-)-flurbiprofen[35]

side effect: Äge neerukahjustus

(RS)-ketoprofen[35]

side effect: Äge neerukahjustus

(RS)-etodolac[35]

side effect: Äge neerukahjustus

sulindac[35]

side effect: Äge neerukahjustus

parecoxib[35]

side effect: Äge neerukahjustus

aceclofenac[35]

side effect: Äge neerukahjustus

tenoxicam[35]

side effect: Äge neerukahjustus

bromocriptine[34]

side effect: Hüpotensioon

droperidol[34]

side effect: Hüpotensioon

lisinopril dihydrate[34]

side effect: Hüpotensioon

quinapril[34]

side effect: Hüpotensioon

ramipril[34]

side effect: Hüpotensioon

captopril[34]

side effect: Hüpotensioon

enalapril[34]

side effect: Hüpotensioon

trandolapril[34]

side effect: Hüpotensioon

fosinopril[34]

side effect: Hüpotensioon

sotalol[35]

side effect: Hüpotensioon

perindopril[34]

side effect: Hüpotensioon

droperidol[34]

side effect: torsades de pointes

droperidol[34]

side effect: long QT syndrome

droperidol[34]
droperidol[34]

side effect: cardiotoxicity

sotalol[35]

side effect: torsades de pointes

sotalol[35]

side effect: long QT syndrome

sotalol[35]

side effect: cardiotoxicity

Aspiriin[35]

side effect: nephrotoxicity

nabumetone[35]

side effect: nephrotoxicity

Naprokseen[35]

side effect: nephrotoxicity

celecoxib[35]

side effect: nephrotoxicity

Diclofenac[35]

side effect: nephrotoxicity

piroxicam[35]

side effect: nephrotoxicity

meloksikaam[35]

side effect: nephrotoxicity

(RS)-fenoprofen[35]

side effect: nephrotoxicity

(+-)-flurbiprofen[35]

side effect: nephrotoxicity

ibuprofeen[35]

side effect: nephrotoxicity

Indometatsiin[35]

side effect: nephrotoxicity

(RS)-ketoprofen[35]

side effect: nephrotoxicity

(RS)-etodolac[35]

side effect: nephrotoxicity

sulindac[35]

side effect: nephrotoxicity

parecoxib[35]

side effect: nephrotoxicity

aceclofenac[35]

side effect: nephrotoxicity

tenoxicam[35]

side effect: nephrotoxicity

lisinopril dihydrate[34]

side effect: decreased blood pressure

quinapril[34]

side effect: decreased blood pressure

ramipril[34]

side effect: decreased blood pressure

captopril[34]

side effect: decreased blood pressure

enalapril[34]

side effect: decreased blood pressure

trandolapril[34]

side effect: decreased blood pressure

fosinopril[34]

side effect: decreased blood pressure

perindopril[34]

side effect: decreased blood pressure

Diarseentrioksiid[34]

side effect: torsades de pointes

Diarseentrioksiid[34]

side effect: long QT syndrome

dronedarone[34]

side effect: hypomagnesemia

bromocriptine[34]

side effect: hyperglycemia

bromocriptine[34]

side effect: increased insulin requirement

triamcinolone[34]
methylprednisolone[34]
prednisone[34]
fludrocortisone[34]
cortisol[34]

physically interacts with

Solute carrier family 12 member 3[37]

subjektil on roll: Ensüümiinhibiitor

legal status (medicine)

boxed warning[38]

subjektil on roll

antihypertensive drug[39]
diuretic[39]
Sodium Chloride Symporter Inhibitors[39]
essential medicine

stylized name

hydroCHLOROthiazide[40]

väljaandja: Institute for Safe Medication Practices

on omadusega: Tall Man lettering

Commonsi kategooria

Hydrochlorothiazide

Viited

  1. 1,0 1,1 1,2 1,3 1,4 1,5 Global Substance Registration System, 19. november 2016, inglise keel, hydrochlorothiazide, 0J48LPH2TH
  2. CAS Common Chemistry, 9. aprill 2021, JZUFKLXOESDKRF-UHFFFAOYSA-N, https://commonchemistry.cas.org/detail?cas_rn=58-93-5
  3. 3,0 3,1 ChEMBL, 19. november 2016, inglise keel, HYDROCHLOROTHIAZIDE, CHEMBL435
  4. 4,0 4,1 inferred from InChIKey
  5. 5,0 5,1 5,2 5,3 5,4 5,5 JZUFKLXOESDKRF-UHFFFAOYSA-N, InChIKey
  6. ECHA Substance Infocard database, 27. detsember 2018, 100.000.367, Hydrochlorothiazide, CAS no.: 58-93-5
  7. Protein Data Bank, 19. oktoober 2016, inglise keel, 3IK6, 3IK6
  8. Protein Data Bank, 19. oktoober 2016, inglise keel, 3IJX, 3IJX
  9. 9,0 9,1 UniChem
  10. Freebase Data Dumps, 28. oktoober 2013
  11. 11,0 11,1 11,2 11,3 ChEBI, 19. oktoober 2016, inglise keel, hydrochlorothiazide, 5778
  12. 12,0 12,1 12,2 12,3 12,4 PubChem, 19. november 2016, inglise keel, 3639, hydrochlorothiazide
  13. Quora
  14. OpenAlex, 26. jaanuar 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
  15. KBpedia, 9. juuli 2020
  16. ChEBI release 2020-09-01
  17. International Chemical Identifier, InChI=1S/C7H8ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-2,10-11H,3H2,(H2,9,12,13)
  18. Hazardous Substances Data Bank, 10. mai 2021, 28. oktoober 2019, Hydrochlorothiazide, 3096
  19. DrugBank, inglise keel, 17. november 2015, 00999, Hydrochlorothiazide
  20. IUPHAR/BPS Guide to PHARMACOLOGY, 19. november 2016, inglise keel, 4836, hydrochlorothiazide
  21. GF WordNet
  22. Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard
  23. CAB Thesaurus, 6. aprill 2020
  24. ChemSpider, 19. november 2016, inglise keel, 3513, Hydrochlorothiazide
  25. https://mednet-communities.net/inn/db/ViewINN.aspx?i=841
  26. N0000145995, 27. veebruar 2018, NDF-RT
  27. PubChem, 19. oktoober 2016, inglise keel, 3639, hydrochlorothiazide
  28. Jean-Claude Bradley Open Melting Point Dataset
  29. https://www.whocc.no/atc_ddd_index/?code=C03AA03
  30. RxNorm, 218369, 14. veebruar 2018
  31. Recommended INN: List 4, 1962
  32. 32,0 32,1 32,2 32,3 N0000145995, 13. detsember 2016, NDF-RT, inglise keel
  33. Drug Indications Extracted from FAERS, 2. oktoober 2018
  34. 34,00 34,01 34,02 34,03 34,04 34,05 34,06 34,07 34,08 34,09 34,10 34,11 34,12 34,13 34,14 34,15 34,16 34,17 34,18 34,19 34,20 34,21 34,22 34,23 34,24 34,25 34,26 34,27 34,28 34,29 34,30 34,31 34,32 34,33 34,34 34,35 34,36 34,37 34,38 34,39 34,40 34,41 34,42 A reference set of clinically relevant adverse drug-drug interactions, hypothetically
  35. 35,00 35,01 35,02 35,03 35,04 35,05 35,06 35,07 35,08 35,09 35,10 35,11 35,12 35,13 35,14 35,15 35,16 35,17 35,18 35,19 35,20 35,21 35,22 35,23 35,24 35,25 35,26 35,27 35,28 35,29 35,30 35,31 35,32 35,33 35,34 35,35 35,36 35,37 35,38 35,39 35,40 35,41 35,42 35,43 35,44 35,45 35,46 35,47 35,48 35,49 35,50 35,51 35,52 35,53 35,54 35,55 35,56 A reference set of clinically relevant adverse drug-drug interactions, probably
  36. 36,0 36,1 36,2 36,3 A reference set of clinically relevant adverse drug-drug interactions, established
  37. IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 4836, inglise keel
  38. FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links., https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802
  39. 39,0 39,1 39,2 Medical Subject Headings, 15. märts 2018, D006852
  40. https://www.ismp.org/recommendations/tall-man-letters-list, 2. september 2022